{"id":"W2893221436","doi":"10.1016/j.cllc.2018.09.005","title":"Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis","year":2018,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"Grand River Hospital; University of Victoria","funders":"AstraZeneca Canada","keywords":"Medicine; Nivolumab; Pembrolizumab; Internal medicine; Lung cancer; Adverse effect; Hazard ratio; Cohort; Common Terminology Criteria for Adverse Events; Proportional hazards model; Cancer; Oncology; Renal cell carcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001868715,0.000231631,0.0008368852,0.0002471607,0.00003674791,0.00000268221,0.00008467123,0.000131799,0.0002229558],"category_scores_gemma":[0.00005071426,0.0001734825,0.0002801059,0.0006221086,0.0002470995,0.0001065308,0.00004268951,0.0001616497,4.624829e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008895418,"about_ca_system_score_gemma":0.0001859963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600054,"about_ca_topic_score_gemma":0.002290715,"domain_scores_codex":[0.9981286,0.00006580108,0.0008196901,0.0004874923,0.0002425653,0.000255835],"domain_scores_gemma":[0.9985981,0.0001076512,0.0005180202,0.0003275719,0.0003383656,0.0001102688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03545334,0.001206001,0.9507586,0.0001459757,0.002368043,0.000001950806,0.001204609,0.00004372999,0.0005025252,4.488205e-7,0.00002474026,0.008290068],"study_design_scores_gemma":[0.04254398,0.002822033,0.9465124,0.001024172,0.002734226,1.930348e-7,0.0001481198,0.003169916,0.0008498704,4.173288e-7,0.00003185129,0.0001628082],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997382,0.0008199321,0.0000848502,0.0000639721,0.000267894,0.001199754,0.00007503321,0.00001308959,0.00009347285],"genre_scores_gemma":[0.9979605,0.00120445,0.0002850546,0.00009594536,0.0001165678,0.0001007412,0.00002423488,0.00002691419,0.0001855775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00812726,"threshold_uncertainty_score":0.7074413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0193061778944723,"score_gpt":0.3678977620764572,"score_spread":0.3485915841819849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}